The cannabis industry has experienced unprecedented transformation over the past several years, creating both opportunities and complexities for private lenders. As of 2025, the legal framework governing cannabis continues to evolve rapidly, requiring lenders to stay informed about state-by-state developments and federal policy shifts that impact their lending practices.
The Current State of Cannabis Legalization
Since 2023, the cannabis marketplace has matured significantly. Adult recreational use is now legal in over 25 states and U.S. territories, representing a substantial expansion from just a few years ago. Medical cannabis programs operate in nearly 40 states, creating diverse regulatory environments that lenders must navigate carefully.
The industry’s economic footprint has grown substantially, with projections suggesting the U.S. cannabis market could reach $100-150 billion over the next decade. However, this growth trajectory has not been uniform—some established markets have experienced price compression and revenue contraction as oversupply issues and regulatory challenges have emerged.
Recent State Legislative Developments
Several states that were contemplating cannabis legalization in 2023 have made significant progress:
Kentucky’s Medical Cannabis FrameworkKentucky implemented its medical cannabis program after legislation passed in 2023. The program, which became fully operational in January 2025, permits qualifying patients with conditions including cancer, severe chronic pain, epilepsy, multiple sclerosis, and PTSD to access cannabis products through licensed dispensaries. While smoking remains prohibited, patients can purchase raw cannabis for alternative consumption methods. The state does not permit home cultivation, and patients may possess a 30-day supply at their residence and a 10-day supply when traveling.
Ohio’s Recreational MarketOhio voters approved recreational cannabis in November 2023, and the state has since established a regulatory framework for adult-use sales. Adults 21 and older may purchase and possess cannabis products through licensed retailers, significantly expanding the state’s cannabis economy beyond its existing medical program.
Minnesota’s Adult-Use AuthorizationMinnesota legalized adult-use cannabis in 2023, permitting adults 21 and older to purchase up to two ounces of cannabis and cultivate up to eight plants (four mature). The legislation allows possession of up to two ounces in public and five pounds in private residences, creating one of the more permissive possession frameworks in the country.
Other State MovementsDelaware, Pennsylvania, Hawaii, and New Hampshire have all made progress toward cannabis reform, with varying approaches ranging from full legalization to decriminalization and medical expansion. Each state’s unique regulatory structure creates distinct lending considerations for private capital providers.
Federal Law Considerations in 2025
Despite widespread state-level legalization, cannabis remains classified as a Schedule I controlled substance under federal law. This classification designates cannabis as having high abuse potential with no accepted medical use—a characterization increasingly at odds with state policies and emerging medical research.
The 2022 passage of the Medical Marijuana and Cannabidiol Research Expansion Act represented Congress’s first standalone cannabis legislation, signaling potential future federal reform. Additionally, the Biden administration’s 2022 directive to review cannabis scheduling and pardon simple possession offenses suggested shifting federal priorities.
However, as of 2025, comprehensive federal legalization has not occurred, leaving lenders to navigate the complex intersection of state-authorized commerce and federal prohibition.
Critical Considerations for Cannabis Lending
The cannabis sector presents unique challenges for commercial lenders that require specialized expertise:
Regulatory ComplexityEach state maintains distinct licensing requirements, operational restrictions, product limitations, and taxation structures. Lenders must thoroughly understand the regulatory environment in each jurisdiction where borrowers operate.
Collateral Valuation ChallengesCannabis-related assets—including cultivation facilities, processing equipment, inventory, and intellectual property—require specialized valuation approaches. Traditional appraisal methods often fail to capture the unique risk-reward dynamics of cannabis collateral.
Documentation RequirementsCannabis lending transactions demand meticulous documentation that addresses both state compliance obligations and federal law considerations. Loan agreements must carefully define permissible uses of proceeds, establish robust reporting requirements, and incorporate protective covenants tailored to cannabis operations.
Banking and Financial Services RestrictionsLimited banking access for cannabis operators creates operational complexities. Lenders must structure transactions that account for cash-intensive business models and restricted access to traditional financial services.
Risk Management FrameworksEffective cannabis lending requires comprehensive due diligence covering licensure verification, regulatory compliance history, operational capabilities, market positioning, and management experience. Lenders must implement ongoing monitoring systems to detect compliance lapses or regulatory changes that could impact borrower performance.
Structuring Cannabis-Related Loans
Private lenders extending capital to cannabis businesses should implement several best practices:
Comprehensive Collateral Documentation: Perfect security interests in all available collateral, including real property, equipment, inventory, intellectual property, and accounts receivable. Understand state-specific restrictions on collateral enforcement.
Opportunities in Cannabis Finance
Despite regulatory complexity, the cannabis sector offers substantial opportunities for well-informed private lenders. The industry’s limited access to traditional bank financing creates demand for alternative capital sources. Lenders who develop specialized cannabis expertise can command premium pricing while serving borrowers in a high-growth sector.
Key opportunity areas include:
– Real estate financing for cultivation and dispensary facilities
– Equipment financing for processing and testing operations
– Working capital facilities for licensed operators with established operations
– Acquisition financing as industry consolidation accelerates
– Construction loans for purpose-built cannabis facilities
Looking Forward
The cannabis industry’s legal landscape will continue evolving throughout 2025 and beyond. Additional states are expected to consider legalization, while existing programs will mature and potentially undergo regulatory refinement.
Federal policy developments—including potential rescheduling or banking reform—could fundamentally alter the industry’s risk profile. Lenders must maintain vigilance regarding legislative and regulatory changes at both state and federal levels.
For private lenders considering cannabis-related lending opportunities, specialized legal guidance is essential. Geraci LLP has extensive experience structuring cannabis loans that balance commercial opportunity with legal and regulatory compliance.
The cannabis sector represents one of the most dynamic areas of private lending, offering substantial returns for lenders who approach the space with appropriate expertise, thorough due diligence, and carefully structured transactions.
Geraci LLP provides comprehensive legal services for private lenders engaging in cannabis-related lending. Our attorneys have deep experience navigating the complex state and federal regulatory landscape governing cannabis finance. Contact our team to discuss your cannabis lending transactions.
